R

Regencell Bioscience Holdings Limited
D

RGC

30.020
USD
-5.11
(-14.55%)
قبل الجلسة
حجم التداول
67
الربح لكل سهم
0
العائد الربحي
-
P/E
-4,236
حجم السوق
14,844,557,018
أصول ذات صلة المقالات

العنوان: Regencell Bioscience Holdings Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.